Corcept's ovarian cancer drug meets main goal in late-stage study, shares jump
Corcept Therapeutics said on Monday its experimental combination ovarian cancer drug improved survival in patients with a ...
Corcept Therapeutics Shares Soar on Positive Ovarian Cancer Treatment Trial Results
Corcept Therapeutics shares nearly doubled in premarket trading Monday after the company said it received positive data from its phase 3 ovarian cancer treatment trial. Shares rose 93% ahead of the ...
Aspira Women's Health: Aspira Receives $1.5 million Milestone Payment from the ARPA-H Sprint for Women's Health Award
The Company Successfully Reaches the Second Milestone of ARPA-H $10 Million Award AUSTIN, TX / ACCESS Newswire / March 31, 2025 / Aspira Women's Health Inc. ("Aspira") (NASDAQ:AWH), a bio-analytical b ...
LIXTE Launches New Study to Determine if Certain Pre-Cancerous Cells Found in an Aging Population Can Be Eliminated by LB-100
Pre-Clinical Study in Collaboration with Netherlands Cancer Instituteis in addition to LIXTE’s Ongoing Clinical Trials for ...